Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) saw a significant increase in short interest in the month of August. As of August 15th, there was short interest totalling 3,850,000 shares, an increase of 25.4% from the July 31st total of 3,070,000 shares. Based on an average daily trading volume, of 1,350,000 shares, the short-interest ratio is presently 2.9 days. Approximately 6.7% of the shares of the company are sold short.
Analyst Ratings Changes
A number of research analysts have recently issued reports on TEM shares. Piper Sandler started coverage on Tempus AI in a report on Monday, August 12th. They issued a "neutral" rating and a $40.00 target price on the stock. Longbow Research started coverage on Tempus AI in a report on Tuesday, July 9th. They issued a "buy" rating and a $48.00 target price on the stock. Bank of America started coverage on Tempus AI in a report on Tuesday, July 9th. They issued a "buy" rating and a $41.00 target price on the stock. Needham & Company LLC reissued a "buy" rating and issued a $47.00 target price on shares of Tempus AI in a report on Wednesday, August 7th. Finally, William Blair started coverage on Tempus AI in a report on Tuesday, July 9th. They issued an "outperform" rating on the stock. One equities research analyst has rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $45.56.
Get Our Latest Report on Tempus AI
Institutional Trading of Tempus AI
Institutional investors have recently bought and sold shares of the company. NEA Management Company LLC purchased a new stake in shares of Tempus AI in the second quarter valued at $160,048,000. Novo Holdings A S purchased a new stake in shares of Tempus AI in the second quarter valued at $142,605,000. Revolution Growth Management Company Inc. purchased a new stake in shares of Tempus AI in the second quarter valued at $128,133,000. Alphabet Inc. purchased a new stake in shares of Tempus AI in the second quarter valued at $54,289,000. Finally, Lingotto Investment Management LLP purchased a new position in Tempus AI during the second quarter worth about $32,685,000.
Tempus AI Price Performance
TEM stock traded up $1.47 on Friday, reaching $59.38. 715,263 shares of the company's stock were exchanged, compared to its average volume of 1,235,011. The company has a fifty day moving average of $42.94. Tempus AI has a twelve month low of $22.89 and a twelve month high of $77.00.
Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing analysts' consensus estimates of ($4.41) by ($2.36). The business had revenue of $165.97 million during the quarter, compared to the consensus estimate of $159.10 million. Equities research analysts expect that Tempus AI will post -6.51 earnings per share for the current fiscal year.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.